“(We) got together and said we need intervention to fill the gap,” said Marla Schneider, President/CEO of GMED. “We do need a full-time person here to help move housing forward, we believe that’s our ...

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In simpler terms, it measures the profitability of a company in relation to ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions ...

On Wednesday, Globus Medical Inc (GMED) stock saw a modest uptick, ending the day at $75.07 which represents a slight increase of $0.78 or 1.05% from the prior close of $74.29. The stock opened at $74 ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

Check the time stamp on this data. Updated AI-Generated Signals for Globus Medical Inc. Class A (GMED) available here: GMED.

LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical ...

Globus Medical, Inc. (NYSE: GMED) is showcasing its latest advancements in orthopedic technology at the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, from ...

Wells Fargo has recently raised Globus Medical Inc (GMED) stock to Overweight rating, as announced on August 7, 2024, according to Finviz. Earlier, on May 20, 2024, Piper Sandler had raised the stock ...